108 related articles for article (PubMed ID: 20441994)
1. The clinicopathologic values of the molecules associated with the main pathogenesis of the glioblastoma.
Kim B; Myung JK; Seo JH; Park CK; Paek SH; Kim DG; Jung HW; Park SH
J Neurol Sci; 2010 Jul; 294(1-2):112-8. PubMed ID: 20441994
[TBL] [Abstract][Full Text] [Related]
2. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
3. Pediatric glioblastomas: a histopathological and molecular genetic study.
Suri V; Das P; Pathak P; Jain A; Sharma MC; Borkar SA; Suri A; Gupta D; Sarkar C
Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259
[TBL] [Abstract][Full Text] [Related]
4. Clinical and immunohistochemical prognostic factors in adult glioblastoma patients.
Umesh S; Tandon A; Santosh V; Anandh B; Sampath S; Chandramouli BA; Sastry Kolluri VR
Clin Neuropathol; 2009; 28(5):362-72. PubMed ID: 19788052
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
Haas-Kogan DA; Prados MD; Tihan T; Eberhard DA; Jelluma N; Arvold ND; Baumber R; Lamborn KR; Kapadia A; Malec M; Berger MS; Stokoe D
J Natl Cancer Inst; 2005 Jun; 97(12):880-7. PubMed ID: 15956649
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients.
Ganigi PM; Santosh V; Anandh B; Chandramouli BA; Sastry Kolluri VR
Pediatr Neurosurg; 2005; 41(6):292-9. PubMed ID: 16293948
[TBL] [Abstract][Full Text] [Related]
7. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
Ruano Y; Ribalta T; de Lope AR; Campos-Martín Y; Fiaño C; Pérez-Magán E; Hernández-Moneo JL; Mollejo M; Meléndez B
Am J Clin Pathol; 2009 Feb; 131(2):257-63. PubMed ID: 19141386
[TBL] [Abstract][Full Text] [Related]
8. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
Lee HJ; Xu X; Choe G; Chung DH; Seo JW; Lee JH; Lee CT; Jheon S; Sung SW; Chung JH
Lung Cancer; 2010 Jun; 68(3):375-82. PubMed ID: 19712993
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.
Kraus JA; Glesmann N; Beck M; Krex D; Klockgether T; Schackert G; Schlegel U
J Neurooncol; 2000 Jun; 48(2):89-94. PubMed ID: 11083071
[TBL] [Abstract][Full Text] [Related]
10. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status.
Navarro L; Gil-Benso R; Megías J; Muñoz-Hidalgo L; San-Miguel T; Callaghan RC; González-Darder JM; López-Ginés C; Cerdá-Nicolás MJ
Neuroscience; 2015 Jun; 297():243-51. PubMed ID: 25869624
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors.
Layfield LJ; Willmore C; Tripp S; Jones C; Jensen RL
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):91-6. PubMed ID: 16540738
[TBL] [Abstract][Full Text] [Related]
12. DJ-1 expression in glioblastomas shows positive correlation with p53 expression and negative correlation with epidermal growth factor receptor amplification.
Hinkle DA; Mullett SJ; Gabris BE; Hamilton RL
Neuropathology; 2011 Feb; 31(1):29-37. PubMed ID: 20497343
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical investigation of p53 and EGFR expression of oligodendrogliomas.
Broholm H; Bols B; Heegaard S; Braendstrup O
Clin Neuropathol; 1999; 18(4):176-80. PubMed ID: 10442459
[TBL] [Abstract][Full Text] [Related]
14. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.
Simmons ML; Lamborn KR; Takahashi M; Chen P; Israel MA; Berger MS; Godfrey T; Nigro J; Prados M; Chang S; Barker FG; Aldape K
Cancer Res; 2001 Feb; 61(3):1122-8. PubMed ID: 11221842
[TBL] [Abstract][Full Text] [Related]
15. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
16. Akt/protein kinase B overexpression as an accurate prognostic marker in adult diffuse astrocytoma.
Matsutani T; Nagai Y; Mine S; Murai H; Saeki N; Iwadate Y
Acta Neurochir (Wien); 2009 Mar; 151(3):263-8; discussion 268. PubMed ID: 19240976
[TBL] [Abstract][Full Text] [Related]
17. Rhabdoid glioblastoma is distinguishable from classical glioblastoma by cytogenetics and molecular genetics.
Byeon SJ; Cho HJ; Baek HW; Park CK; Choi SH; Kim SH; Kim HK; Park SH
Hum Pathol; 2014 Mar; 45(3):611-20. PubMed ID: 24457079
[TBL] [Abstract][Full Text] [Related]
18. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
Burton EC; Lamborn KR; Forsyth P; Scott J; O'Campo J; Uyehara-Lock J; Prados M; Berger M; Passe S; Uhm J; O'Neill BP; Jenkins RB; Aldape KD
Clin Cancer Res; 2002 Jan; 8(1):180-7. PubMed ID: 11801556
[TBL] [Abstract][Full Text] [Related]
19. In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression.
Miracco C; De Santi MM; Luzi P; Lalinga AV; Laurini L; De Nisi MC; Angeloni G; Brogi M; Cardone C; Carducci A; Arcuri F; Tosi P; Rubino G; Pirtoli L
Int J Oncol; 2003 Dec; 23(6):1529-35. PubMed ID: 14612923
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.
Newcomb EW; Cohen H; Lee SR; Bhalla SK; Bloom J; Hayes RL; Miller DC
Brain Pathol; 1998 Oct; 8(4):655-67. PubMed ID: 9804374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
